Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06410261

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

Led by University of Illinois at Chicago · Updated on 2024-09-20

24

Participants Needed

1

Research Sites

169 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Approximately 50% of people with multiple sclerosis (MS) use a wheelchair within 30 years of the initial diagnosis. Wheelchair use in MS is often associated with fatigue as a consequence of muscle weakness. Indeed, fatigue, a prevalent consequence of MS, often becomes debilitating and exhausts energetic resources when carrying-out tasks of daily life and/or interacting with the community, as these require ambulatory mobility. This experience of excessive fatigue has its roots in muscle weakness and results in reliance on a wheelchair for mobility, and the dependency on a wheelchair may further reduce muscular strength, particularly of the lower extremities. We propose that wheelchair users with MS can increase muscular strength through a personalized exercise rehabilitation, and this in turn will improve ambulatory performance and possibly reduce fatigue. To date, no research has examined the effects of this specific exercise rehabilitation program (GH method) on physical function and other disease-related outcomes in persons with MS who use wheelchairs as a primary mobility device.

CONDITIONS

Official Title

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of multiple sclerosis
  • Age above 18 years
  • No relapse within the last 30 days
  • Use wheelchair for mobility in the community
  • Able to walk at least 50 feet or 65 steps using an assistive device
  • Low risk for physical activity contraindications with no more than one "yes" on the Physical Activity Readiness Questionnaire (PAR-Q)
  • Willingness to complete assessments and undergo randomization
Not Eligible

You will not qualify if you...

  • No diagnosis of multiple sclerosis
  • Under 18 years of age
  • Had a relapse within the last 30 days
  • Do not use a wheelchair as primary mobility device
  • Unable to walk at least 50 feet or 65 steps
  • High risk for physical activity contraindications with more than one "yes" on the PAR-Q
  • Not willing to complete testing procedures or undergo randomization

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Illinois at Chicago

Chicago, Illinois, United States, 60612

Actively Recruiting

Loading map...

Research Team

E

Enrico Benedetti, MD

CONTACT

I

Ilaria Santi

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here